Management of breakthrough pain due to cancer - The Simmonds article reviewed

被引:0
作者
Manfredi, P [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, Pain & Palliat Care Serv, New York, NY 10021 USA
来源
ONCOLOGY-NEW YORK | 1999年 / 13卷 / 08期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1113 / 1114
页数:2
相关论文
共 3 条
[1]  
[Anonymous], 1994, AHCPR PUBLICATION
[2]   BREAKTHROUGH PAIN - DEFINITION, PREVALENCE AND CHARACTERISTICS [J].
PORTENOY, RK ;
HAGEN, NA .
PAIN, 1990, 41 (03) :273-281
[3]   Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study [J].
Portenoy, RK ;
Payne, R ;
Coluzzi, P ;
Raschko, JW ;
Lyss, A ;
Busch, MA ;
Frigerio, V ;
Ingham, J ;
Loseth, DB ;
Nordbrock, E ;
Rhiner, M .
PAIN, 1999, 79 (2-3) :303-312